Genetic manipulation of insulin action and beta-cell function in mice (Q40857246)

24 September 2017

title

Genetic manipulation of insulin action and beta-cell function in mice (English)

1 reference

24 September 2017

Lamothe B

1

1 reference

24 September 2017

Duvillié B

2

1 reference

24 September 2017

Cordonnier N

3

1 reference

24 September 2017

Baudry A

4

1 reference

24 September 2017

Saint-Just S

5

1 reference

24 September 2017

Bucchini D

6

1 reference

24 September 2017

Jami J

7

1 reference

24 September 2017

Joshi RL

8

1 reference

24 September 2017

publication date

1 May 1998

1 reference

Molecular and Cellular Biochemistry

24 September 2017

published in

1 reference

24 September 2017

volume

182

1 reference

24 September 2017

issue

1-2

1 reference

24 September 2017

page(s)

161-168

1 reference

Expression of an insulin-responsive glucose transporter (GLUT4) minigene in transgenic mice: effect of exercise and role in glucose homeostasis

24 September 2017

cites work

1 reference

12 December 2020

Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality

1 reference

12 December 2020

Increased glycogen accumulation in transgenic mice overexpressing glycogen synthase in skeletal muscle

1 reference

12 December 2020

Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle

1 reference

12 December 2020

Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity.

1 reference

12 December 2020

Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.

1 reference

12 December 2020

Adaptation to supraphysiologic levels of insulin gene expression in transgenic mice: evidence for the importance of posttranscriptional regulation

1 reference

12 December 2020

A mutant human proinsulin is secreted from islets of Langerhans in increased amounts via an unregulated pathway

1 reference

12 December 2020

Transgenic approaches to the pathogenesis of NIDDM.

1 reference

12 December 2020

Calmodulin-induced early-onset diabetes in transgenic mice

1 reference

12 December 2020

Animal models of non‐insulin‐dependent diabetes

1 reference

12 December 2020

Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4

1 reference

12 December 2020

Formation of islet amyloid fibrils in beta-secretory granules of transgenic mice expressing human islet amyloid polypeptide/amylin

1 reference

12 December 2020

The insulin-like growth factor-I receptor. Structure, ligand-binding mechanism and signal transduction.

1 reference

12 December 2020

Candidate genes for insulin resistance.

1 reference

12 December 2020

Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue

1 reference

12 December 2020

Inhibition of pancreatic beta-cell glucokinase by antisense RNA expression in transgenic mice: mouse strain-dependent alteration of glucose tolerance

1 reference

12 December 2020

Glucose transport activity in skeletal muscles from transgenic mice overexpressing GLUT1. Increased basal transport is associated with a defective response to diverse stimuli that activate GLUT4.

1 reference

12 December 2020

Overexpression of hexokinase II in transgenic mice. Evidence that increased phosphorylation augments muscle glucose uptake

1 reference

12 December 2020

A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting.

1 reference

12 December 2020

Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM).

1 reference

12 December 2020

Expression of GLUT-2 antisense RNA in beta cells of transgenic mice leads to diabetes

1 reference

12 December 2020

Hyperinsulinemia in transgenic mice carrying multiple copies of the human insulin gene.

1 reference

12 December 2020

Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene

1 reference

12 December 2020

Insulin action impaired by deficiency of the G-protein subunit G ialpha2

1 reference

12 December 2020

Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes

1 reference

12 December 2020

Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle.

1 reference

12 December 2020

High fat diet-induced hyperglycemia: prevention by low level expression of a glucose transporter (GLUT4) minigene in transgenic mice

1 reference

12 December 2020

Pancreatic beta-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose

1 reference

12 December 2020

Expression of yeast hexokinase in pancreatic beta cells of transgenic mice reduces blood glucose, enhances insulin secretion, and decreases diabetes

1 reference

12 December 2020

Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4).

1 reference

12 December 2020

Germline manipulation of glucose homeostasis via alteration of glucose transporter levels in skeletal muscle.

1 reference

12 December 2020

Hormonal/metabolic regulation of the human GLUT4/muscle-fat facilitative glucose transporter gene in transgenic mice.

1 reference

12 December 2020

Altering mice by homologous recombination using embryonic stem cells

1 reference

12 December 2020

Transgenic mice with muscle-specific insulin resistance develop increased adiposity, impaired glucose tolerance, and dyslipidemia.

1 reference

12 December 2020

Early neonatal death in mice homozygous for a null allele of the insulin receptor gene

1 reference

12 December 2020

Transgenic knockouts reveal a critical requirement for pancreatic beta cell glucokinase in maintaining glucose homeostasis

1 reference

12 December 2020

Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene.

1 reference

12 December 2020

Abnormal brown and white fat development in transgenic mice overexpressing glycerol 3-phosphate dehydrogenase

1 reference

12 December 2020

Ribozyme-mediated attenuation of pancreatic beta-cell glucokinase expression in transgenic mice results in impaired glucose-induced insulin secretion

1 reference

12 December 2020

Molecular physiology of the islet amyloid polypeptide (IAPP)/amylin gene in man, rat, and transgenic mice

1 reference

12 December 2020

Pancreatic expression of human insulin gene in transgenic mice.

1 reference

12 December 2020

Regulation of human insulin gene expression in transgenic mice

1 reference

12 December 2020

Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1.

1 reference

12 December 2020

Correction of diabetic alterations by glucokinase.

1 reference

12 December 2020

Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A

1 reference

12 December 2020

Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)

1 reference

12 December 2020

Constitutive (pro)insulin release from pancreas of transgenic mice expressing monomeric insulin

1 reference

12 December 2020

Skeletal muscle glucose transport and metabolism are enhanced in transgenic mice overexpressing the Glut4 glucose transporter

1 reference

12 December 2020

Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle

1 reference

12 December 2020

High level overexpression of glucose transporter-4 driven by an adipose-specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance

1 reference

12 December 2020

Regulated expression of an insulin-responsive glucose transporter (GLUT4) minigene in 3T3-L1 adipocytes and transgenic mice

1 reference

12 December 2020

Expression of human GLUT4 in mice results in increased insulin action

1 reference

12 December 2020

Muscle-Specific Expression of Human Insulin Receptor in Transgenic Mice

1 reference

12 December 2020

Characterization of Insulin Resistance and NIDDM in Transgenic Mice With Reduced Brown Fat

1 reference

12 December 2020

Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

A new transgenic mouse model of chronic hyperglycemia

1 reference

12 December 2020

Insulin stimulation of mitogen-activated protein kinase, p90rsk, and p70 S6 kinase in skeletal muscle of normal and insulin-resistant mice. Implications for the regulation of glycogen synthase.

1 reference

12 December 2020

The diabetogenes concept of NIDDM.

1 reference

12 December 2020

Differential effects of GLUT-1 or GLUT-4 overexpression on insulin responsiveness in transgenic mice.

1 reference

12 December 2020

[Val12] HRAS downregulates GLUT2 in beta cells of transgenic mice without affecting glucose homeostasis

1 reference

12 December 2020

Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice.

1 reference

12 December 2020

Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM?

1 reference

12 December 2020

Impaired insulin signaling in skeletal muscles from transgenic mice expressing kinase-deficient insulin receptors

1 reference

12 December 2020

IGF-I is required for normal embryonic growth in mice

1 reference

12 December 2020

Development of obesity in transgenic mice after genetic ablation of brown adipose tissue

1 reference

12 December 2020

Expression of the gene encoding the tyrosine kinase-deficient human insulin receptor in transgenic mice

1 reference

12 December 2020

Expression of a dominant-negative mutant human insulin receptor in the muscle of transgenic mice

1 reference

12 December 2020

Human islet amyloid polypeptide accumulates at similar sites in islets of transgenic mice and humans

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1006813712567

1 reference

Dimensions Publication ID

24 September 2017

1041405222

0 references

1 reference